SCHEMBL18464422

SCHEMBL18464422

C/C=N\C(=N/CO)Nc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ TAS2R38 P59533 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ NAPRT Q6XQN6 1/20 0.37
▸ CXCR4 P61073 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ EPHX1 P07099 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ EPHX2 P34913 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ GAA P10253 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TGM2 P21980 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19145310 0.72 SMN1; SMN2 (0.44) SMN1; SMN2TAS2R38HSD17B10NAPRTCYP1A2
SCHEMBL11144243 0.71 TAS2R38 (0.44) SMN1; SMN2TAS2R38HSD17B10NAPRTCXCR4
SCHEMBL22606375 0.71 CXCR4 (0.39) SMN1; SMN2TAS2R38HSD17B10NAPRTCXCR4
SCHEMBL2914537 0.71 NAPRT (0.52) SMN1; SMN2HSD17B10NAPRTCYP1A2NPSR1
SCHEMBL14543949 0.67 SMN1; SMN2 (0.35) SMN1; SMN2TAS2R38HSD17B10NAPRTTP53
SCHEMBL11183534 0.64 MTOR (0.47) SMN1; SMN2HSD17B10NAPRTCYP1A2NPSR1
SCHEMBL5157140 0.64 TAS2R38 (0.52) SMN1; SMN2TAS2R38HSD17B10NAPRTCYP1A2
SCHEMBL18676955 0.64 TAS2R38 (0.52) SMN1; SMN2TAS2R38HSD17B10NAPRTCYP1A2
SCHEMBL13513997 0.63 NPC1 (0.53) SMN1; SMN2HSD17B10NAPRTCYP1A2NPSR1
SCHEMBL12113186 0.62 MAPT (0.61) SMN1; SMN2TAS2R38HSD17B10NAPRTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017019804-A2 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2017-02-02 — — WO disclosed
Send feedback